Gannett Vs. Keros Therapeutics Industry Stock Comparison

Buy

55

GCI
Gannett

Last Price:

4.46

Seasonality Move:

-0.83%

Sell

25

KROS
Keros Therapeutics

Last Price:

45.28

Seasonality Move:

4.22%

Buy

55

Gannett (GCI) is a Buy

Is Gannett a Buy, Sell or Hold?

The current Gannett [GCI] share price is $4.60. The Score for GCI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
GCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

25

Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GCI Stock Price Chart

What is Gannett's stock price today?

The Gannett share price today is $4.60
The current trend is moderately bullish and GCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

GCI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.3	Buy
Relative Strength Index (14 RSI):	75.82	Buy
Chaikin Money Flow:	1893511	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.68 - 4.42)	Buy
Bollinger Bands (100):	(2.03 - 3.65)	Buy

KROS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.91	Sell
Relative Strength Index (14 RSI):	36.74	Sell
Chaikin Money Flow:	-120480	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(46.18 - 50.06)	Sell
Bollinger Bands (100):	(50.42 - 64.92)	Sell

GCI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.43	Buy
20-day SMA:	4.18	Buy
50-day SMA:	3.47	Buy
200-day SMA:	2.58	Buy
8-day EMA:	4.42	Buy
20-day EMA:	4.17	Buy
50-day EMA:	3.62	Buy
200-day EMA:	2.81	Buy

KROS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	46.5	Sell
20-day SMA:	47.57	Sell
50-day SMA:	52.43	Sell
200-day SMA:	46.94	Sell
8-day EMA:	46.46	Sell
20-day EMA:	48	Sell
50-day EMA:	51.59	Sell
200-day EMA:	50.14	Sell

Gannett Earnings Growth & GCI Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.10 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Gannett Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25
	Jun
	11	12	13	14	17	18	20	21	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25
	Jun
	11	12	13	14	17	18	20	21	24	25
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):